FTO (Freedom to Operate) in the Pharmaceutical Industry
(Sprache: Englisch)
FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into...
Leider schon ausverkauft
Buch (Kartoniert)
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „FTO (Freedom to Operate) in the Pharmaceutical Industry “
Klappentext zu „FTO (Freedom to Operate) in the Pharmaceutical Industry “
FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed.The author is Hirotaka Nonaka; an attorney-at-law and patent attorney in Tokyo, Japan, handling particularly IP-related disputes and consulting.
Bibliographische Angaben
- Autor: Hirotaka Nonaka
- 2018, 63 Seiten, Maße: 15,4 x 22,7 cm, Kartoniert (TB), Englisch
- Verlag: Nomos
- ISBN-10: 3848752212
- ISBN-13: 9783848752218
- Erscheinungsdatum: 14.08.2018
Sprache:
Englisch
Kommentar zu "FTO (Freedom to Operate) in the Pharmaceutical Industry"
Schreiben Sie einen Kommentar zu "FTO (Freedom to Operate) in the Pharmaceutical Industry".
Kommentar verfassen